MedTrace Logo

Wearability of and Myopia Progression With ZEISS MyoCare Spectacle Lenses

NCT07021560 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-06-15

No results posted yet for this study

Summary

This is a clinical trial evaluating the wearability and effectiveness of three types of ZEISS spectacle lenses in controlling myopia progression. This study compares ZEISS MyoCare spectacle lenses with two types of single-vision spectacle lenses over a 6-month period. This trial aims to evaluate how well these lenses are worn and their impact on myopia progression, including changes in axial length and refractive error.

Participants will be randomly assigned to wear one of three types of ZEISS spectacle lenses. The study will require five visits to the eye clinic over a 6-month period and two virtual follow-up visits.

Conditions

  • Myopia

Interventions

DEVICE

ZEISS MyoCare spectacle lenses

Spectacle lenses with conventional power profile including myopia control design.

DEVICE

ZEISS SV RX SPH 1.5

Commercially available single vision

DEVICE

ZEISS Clearview

Commercially available single vision

Sponsors & Collaborators

  • ZEISS Vision Care

    lead INDUSTRY

Principal Investigators

  • Chi Hoang Viet Vu, MD · Hanoi Eye Hospital 2

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-27
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07021560 on ClinicalTrials.gov